Insider Trading & Ownership of George A. Scangos

Location
San Francisco, CA
Summary
The estimated net worth of George A. Scangos is at least $13,533,227 dollars as of 23 Mar 2026. George A. Scangos is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $8.33M. George A. Scangos is the Director of AGILENT TECHNOLOGIES, INC. and owns shares of AGILENT TECHNOLOGIES, INC. (A) stock worth about $5.21M.
Signature
/s/ Shirley Qin, attorney-in-fact for Dr. Scangos
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow George A. Scangos and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • George A. Scangos has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $13,533,227.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Vir Biotechnology, Inc. ($8,326,163).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of George A. Scangos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VIR Vir Biotechnology, Inc. Director $8,326,163 24 Feb 2025
A AGILENT TECHNOLOGIES, INC. Director $5,207,064 19 Mar 2026
VYGR Voyager Therapeutics, Inc. Director 03 Jun 2025

Insider Transactions Reported by George A. Scangos:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .